RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
44.83
-0.22 (-0.49%)
Nov 22, 2024, 4:00 PM EST - Market closed

RxSight Revenue

RxSight had revenue of $35.31M in the quarter ending September 30, 2024, with 59.08% growth. This brings the company's revenue in the last twelve months to $128.29M, up 67.52% year-over-year. In the year 2023, RxSight had annual revenue of $89.08M with 81.77% growth.

Revenue (ttm)
$128.29M
Revenue Growth
+67.52%
P/S Ratio
13.20
Revenue / Employee
$343,029
Employees
374
Market Cap
1.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202389.08M40.07M81.77%
Dec 31, 202249.01M26.41M116.90%
Dec 31, 202122.59M7.92M53.92%
Dec 31, 202014.68M12.44M554.98%
Dec 31, 20192.24M1.66M284.09%
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Dec 31, 2004 Pro Pro Pro
Dec 31, 2003 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.59B
Integra LifeSciences Holdings 1.56B
Evotec SE 866.67M
GoodRx Holdings 790.39M
Harmony Biosciences Holdings 681.88M
NovoCure 577.74M
Arvinas 161.10M
Tarsus Pharmaceuticals 129.62M
Revenue Rankings